One magnetic nanoparticle images and heats mouse placentas in an ectopic pregnancy study

The smartest choice in the design from Olena Taratula's group at Oregon State and its collaborators at Oregon Health & Science University is the target: the placenta ^[1]. About 98% of ectopic implants sit in a fallopian tube, where they put women at risk of hemorrhage and death ^[6]. "Effective detection of the growing placenta greatly improves the accuracy and timeliness of ectopic pregnancy identification," Taratula said ^[12]. According to the Oregon State account, in a patient a scan with the particles would quickly show whether the placenta is where it should be ^[11].

The treatment step has a temperature cap. "We developed an MRI-guided magnetic nanoplatform for localized hyperthermia, less than or equal to 45 degrees Celsius, of pregnancy-associated tissue," said Karthickraja Duraisamy, the postdoctoral scholar who is the paper's first author ^[15][2]. In pregnant mice, he said, it "selectively disrupted gestational sacs while preserving surrounding uterine tissue and fertility" ^[16].

The thing this doesn't tell you is whether the method works where an ectopic pregnancy actually grows. The tissue Duraisamy says was spared is uterine ^[16], so the heated sacs appear to have been in the uterus. Taratula described the study's main goal as evaluating the particle's "ability to identify and visualize the developing placenta and demonstrate its magnetic hyperthermia capabilities" ^[18]. The account does not describe mice carrying a placenta in a fallopian tube, and it does not say how many animals were used or how often the MRI found the placenta. Two questions stay open. Do the particles gather in a tubal implant as they did in the uterus? Does a tube tolerate heating at 45C as the uterus did ^[15]?

Deaths from ectopic pregnancy are rare in the US. About 30 women a year have died from it over the past six years ^[5]. Against the yearly caseload, that is about 3 deaths per 10,000 cases ^[1]. It is still a leading cause of maternal death in the first trimester ^[3].

In my view, the stronger case for a new method is the harm that stops short of death. Taratula said the current approach of ultrasound, methotrexate and, if needed, surgery is "associated with the risk of tubal rupture and reduced fertility" ^[8]. Methotrexate works by stopping embryonic cells from dividing. Even when it succeeds, she said, it can cause nausea, vomiting, diarrhea, raised liver enzymes, kidney damage and lung disease ^[10]. Having one ectopic pregnancy also raises the risk of another: "a woman who has had one ectopic pregnancy is 10% more likely to have a second one," Taratula said ^[9].